Products
ABP-450 (PrabotulinumtoxinA) | AEON Biopharma, Inc.
Product description
A proprietary botulinum toxin developed by AEON Biopharma for the treatment of various nervous system-related conditions. It is designed as a biosimilar to BOTOX® with the goal of increasing access to effective therapies.